title: [Adherence, pharmacokinetic "tolerance capacity" and HIV resistance development].
authors.affiliation: Klinik für Infektiologie und Spitalhygiene, Universitätsspital Basel.
authors.forename: E
authors.initials: E
authors.lastname: Mossdorf
authors.forename: H H
authors.initials: HH
authors.lastname: Hirsch
mesh_terms: D000328:Adult; D044966:Anti-Retroviral Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D018791:CD4 Lymphocyte Count; D004252:DNA Mutational Analysis; D003937:Diagnosis, Differential; D004334:Drug Administration Schedule; D004338:Drug Combinations; D024921:Drug Resistance, Multiple, Viral / Q000235:genetics; D004359:Drug Therapy, Combination; D006679:HIV Seropositivity / Q000188:drug therapy*; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage* / Q000493:pharmacokinetics; D008297:Male; D019888:Nelfinavir / Q000008:administration & dosage* / Q000493:pharmacokinetics; D016312:Treatment Refusal; D019562:Viral Load; D015215:Zidovudine / Q000008:administration & dosage* / Q000493:pharmacokinetics
chemical_list: D044966:Anti-Retroviral Agents; D004338:Drug Combinations; C109078:lamivudine, zidovudine drug combination; D019259:Lamivudine; D015215:Zidovudine; D019888:Nelfinavir